A Machine-Learning-Based Algorithm for Peptide Feature Detection from Protein Mass Spectrometry Data by Zeng, Xiangyuan
A Machine-Learning-Based Algorithm
for Peptide Feature Detection from




presented to the University of Waterloo
in fulfillment of the




Waterloo, Ontario, Canada, 2021
© Xiangyuan Zeng 2021
Author’s Declaration
I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis,
including any required final revisions, as accepted by my examiners.
I understand that my thesis may be made electronically available to the public.
ii
Abstract
Liquid chromatography with tandem mass spectrometry (LC-MS/MS) has been widely
used in proteomics. Two types of data, MS and MS/MS data, are produced in an LC-
MS/MS experiment. The MS data contains signal peaks corresponding to the intact pep-
tides in the samples being analyzed. However, research on protein mass spectrometry data
has focused more on extracting information from MS/MS data than on MS data. To ef-
fectively utilize MS information, we propose a novel software tool, MSTracer, to detect
peptide features from MS data. Two machine-learning-combined scoring functions were
incorporated in the implementation: one for detecting the peptide features and another
for assigning a quality score to each detected peptide feature. The software was compared
with several other tools and demonstrated significantly better performance.
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1.1 Background and Motivation
Protein is the fundamental functional macromolecule in living organisms and proteomics
is the large scale study of proteins. Ever since the term "proteomics" was coined from
"protein" and "genomics" in the 1990s [20], new protein analysis techniques have emerged,
rapidly evolved, and contributed to large-scale proteomics studies. These techniques are
widely used in cutting edge research ranging from fundamental protein research such as
systems biology to drug discovery [9], biomarker discovery [8], and disease diagnostics [10].
One of the technologies at the forefront of this field, mass spectrometry (MS), is credited for
advancing the development of proteomics on account of its sensitivity, speed, and versatility
[1]. This has resulted in the rapid growth of protein MS data within the proteomics
community, and the emergence of protein MS data platforms such as ProteomeXchange
for standardized proteomics data submission and dissemination worldwide.
In proteomics analysis, proteins are digested by proteases, whereby they are broken
down into pieces to produce a large number of peptides. Mass spectrometry accurately
determines the mass and characteristics of peptides by measuring the mass-to-charge ratio
(m/z) of the peptide ions present. Liquid chromatography (LC) is usually used before
MS for peptide separation. Liquid chromatography with tandem mass spectrometry (LC-
MS/MS) combines LC with multiple quadrupole mass spectrometers and is widely used
to perform bottom-up (or shotgun) proteomics analysis, including protein identification
and quantification. The LC column elutes different peptides at different retention times
(RTs), and an ion source passes through these peptides. The mass analyzer then performs
an MS scan of the coeluting peptide ions periodically, the output of which are the MS1
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spectra. The peptide ions of interest are then selected and fragmented, and further MS/MS
scans are performed by a second mass analyzer, the output of which are the MS2 spectra.
These selected peptide ions are defined as precursor ions. The workflow of LC-MS/MS is
presented in Figure 1.1.
LC Separation
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Protein Digest Ion Source Mass Analyzer
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Figure 1.1: Workflow of LC-MS/MS.
The rich primary structural information of peptide precursors contained in MS2 spectra
have enabled software tools to be optimized to identify and quantify peptides. This is done
either by searching a sequence database (such as Mascot [16], SEQUEST [5], XTandem
[3], PEAKS DB [22], MS-GF+ [12], or MaxQuant [2]) or by de novo sequencing (such as
PEAKS [14],pNovo [21], Novor [13], or PepNovo [6]). However, little attention has been
paid to MS1 spectra.
In MS1 spectra, the elution time window of a peptide usually lasts for several sec-
onds. Peptide ions usually appear in several MS scans during the elution time window.
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A heatmap of MS1 spectra can be plotted with respect to m/z, RT , and intensity (e.g.,
Figures 1.1 & 1.2). MS1 spectra can be used to detect peptide features, which offers several
advantages for bottom-up proteomics analysis. First, they can accurately determine the
charge state, RT , and m/z of the peptide. Such information can be added to the informa-
tion contained in the MS2 spectra to improve the performance of peptide identification.
Second, the peak areas of the peptide features can be used in a label-free quantification
analysis to study changes in the quantity of peptides across multiple samples.
In this research, we aim to develop an algorithm that detects peptide features from
mass spectrometry data with higher accuracy than the existing software applications. The
purpose is to efficiently utilize mass spectrometry data to benefit peptide quantification
and identification.
1.2 MS Peptide Detection and MS/MS Peptide Identi-
fication
1.2.1 Feasibility and Challenges of MS Peptide Detection
Figure 1.2: Heatmap view of MS scan with trails of peptide precursor ions. (A) The full
heatmap view of the MS1 data. (B) An enlarged view of the square area in (A) shows
many trail clusters. Each cluster is a peptide feature. (C) An enlarged view of the square
area in (B) shows two peptide features that overlap slightly.
Peptide feature can be detected from MS1 spectra by searching for certain characteris-
tics on the map. As the heatmap of MS1 spectra illustrates, peptide ions show parallel trails
that are allowed to be detected - these trails are the presentation of isotopes. In nature,
the same chemical elements with different masses are defined as isotopes. A monoisotope
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is one whose elemental composition contains the most abundant isotopes. Each trail rep-
resents the elution profile of an isotope of a peptide over an RT . The trails from a single
peptide, which include a monoisotopic ion and corresponding isotope ions, are collectively
called a peptide feature and can be detected by mass difference. A peptide mainly contains
elements such as carbon (C), hydrogen (H), oxygen (O), nitrogen (N), and sulfur (S), the
lightest isotope of which is the most abundant and is called the monoisotope. Thus, the
trail with the smallest m/z of the peptide feature is usually the monoisotope.
Peptide feature detection can be non-trivial. When peptide features do not overlap,
their detection is rather straightforward. However, when two or more peptide features
overlap (e.g., Figure 1.2 (C)) and when the signal-to-noise ratio of the peptide feature is
low, detection is particularly challenging for computer software and even for human experts.
Existing software applications, such as MaxQuant, Dinosaur, and OpenMS, do not take
these factors into account. In addition, these tools do not provide a quality assessment
system for the reported peptide features. Overall, existing software tools might be affected
by intermingled information on peptide features might affect the performance, and quality
score assignment is lacked in existing software tools. We aim to solve the aforementioned
problems by proposing a tool that performs better than existing software tools and includes
a quality assessment system incorporating machine learning (ML) models.
An ML model automatically learns the underlying rules of a training dataset to predict
future data. Recently, ML has been used by the proteomics community for peptide identifi-
cation analysis with MS. This includes analyzing MS2 data to improve the database search
in the Distiller [16] software tool and de novo sequencing in the Novor [13] and DeepNovo
[19] software applications. Machine learning has also facilitated data-independent acquisi-
tion scan extraction in data dependent-independent acquisition by predicting LC-MS/MS
properties [7]. Since the proteomics community has accumulated a vast amount of mass
spectrometry data, training new ML models is a promising approach for MS data analysis.
1.2.2 MS/MS Peptide Identification
Peptide identification from MS2 spectra is used in training and testing machine learning
models in this research. Identifying peptide can be performed by searching MS2 spec-
tra. In a typical LC-MS/MS setting, the precursor ions are selected for fragmentation
by data-dependent acquisition (DDA). In DDA mode, high-abundant precursor ions are
dynamically selected from the MS scans (Figure 1.3) to produce the MS2 spectra of the
corresponding peptides. Then, the MS2 spectra can be used to identify the peptide with
software. A peptide spectrum match (PSM) is the output of the peptide identification
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Figure 1.3: The enlarged heatmap view of a DDA dataset. The red points indicate which
peptides are selected by instrument for MS/MS events.
tools. If the tools are implemented by database search, a decoy database can be used to
determine the false discovery rate (FDR), which is widely used in quality control.
As mentioned, identifying peptides from MS2 spectra involves in two essential parts: to
build the training dataset for the machine learning models, and to evaluate the sensitivity
of the software tools. The identified peptides allow us to conduct a sensitivity test of our
program output, since their precursor ions are a subset of peptide ions in MS1 spectra with
high confidence. Similarly, the traits of these MS/MS-identified precursor ions contained in
the MS scan can be learned by the ML models to identify high-confidence peptide features
from MS1 spectra.
1.3 Protein MS Datasets
We downloaded protein MS datasets for training and testing purposes. As of format, a
protein MS dataset is a raw MS file (".raw") that is produced by an MS instrument or a
converted file, such as ".mzML", ".mzXML", ".ms1", or ".mgf", derived from a raw file.
The datasets were retrieved from ProteomeXchange, a repository platform that provides
free access to protein MS datasets uploaded by researchers worldwide. Each dataset comes
with at least one raw MS file, and many are with additional search results produced by
search engines given by the provider. The datasets were obtained from experiments on a
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wide range of species, such as human, mouse, yeast, and E. coli with various MS instrument
types, such as Q Exactive, Orbitrap Fusion, and LTQ Orbitrap Velos.
1.4 Contributions
Our main contribution in this thesis is a new and open-source software tool, MSTracer, for
peptide feature detection from MS data. MSTracer is available at https://github.com/
waterlooms/ms-tracer. The manuscript of this research has been submitted to Journal
of Proteome Research at the time of the submission of this thesis, and is under review and
revision. The rest of the thesis is organized as follows:
• In Chapter 2, we review related work, including current peptide detection software
tools and the general method for detecting peptide features.
• In Chapter 3, we describe the training and testing datasets, as well as the procedure
for data processing.
• In Chapter 4, we introduce MSTracer, an ML-combined software tool that detects
peptide features from LC-MS data with enhanced performance and a novel quality
ranking system.
• In Chapter 5, we first present ML models and explain their performance in MSTracer.
We then compare MSTracer with current software tools, such as OpenMS, Dinosaur,
and MaxQuant, in terms of sensitivity and reproducibility. Finally, we analyze the
quality score and the joint use of MSTracer with other software.




In this chapter, we first introduce the common method used in peptide detection. Then, we
review the existing software tools for peptide detection. Lastly, we introduce the MS/MS
search engines that are used in training and testing the ML models.
2.1 Basic Pipeline of Peptide Detection
The pipeline for detecting peptides from raw data generally includes three steps:
• First, centroid MS spectra. Mass spectrometric data produces a cluster of m/z values
for a peptide feature at a certain RT , and the intensities corresponding to these m/z
values fit a Gaussian shape [2]. To accurately identify m/z values, we centroid the
data, which means selecting the peak of each Gaussian curve. In the image on the
left in Figure 2.1(A), the red line represents the peak of the curve and the green
dashed lines are the separation points of the Gaussian curves; the image on the right
shows that all scans are centroided on the map.
• Second, construct the trails of isotopes. Centroided peaks of the same m/z (usually
allowing for a small margin of error) can collectively form a trail on a continuous RT
range.
• Third, cluster the trails into isotopic groups based on the m/z difference. A peptide
produces signals that are identifiable on the MS scans due to the mass difference













(B) Trails constructing (C) Isotope clustering
Figure 2.1: Workflow of basic peptide detection.
proton (1Da). Therefore, given m/z difference, di , the charge state can be deter-





This step is referred as de-isotoping in MaxQuant [2] and as hill clustering and isotope
deconvolution in Dinosaur [18]
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2.2 Existing MS Peptide Detection Tools
We compare our algorithm with three software tools that detect peptide from MS1 spectra,
OpenMS (pyOpenMS library v2.5.0), MaxQuant (v1.16.12.0), and Dinosaur (v1.1.3). The
performance evaluation and comparison are described in Chapter 5. OpenMS was intro-
duced in 2005, followed by the release of its Python library, pyOpenMS, which performs
MS analysis, including peptide detection [17]. In 2008, MaxQuant was published by the
Max-Planck-Institute of Biochemistry [2]. It is the most popular tool as it also supports
peptide identification from MS/MS scans. More recently, in 2016, Dinosaur was developed
not only to detect peaks but also to optimize performance across platforms by automati-
cally auditing and tuning parameters [18]. These software tools and descriptions of their




MaxQuant detects peptides by following the three steps set out in Section 2.1, consum-
ing the raw MS files as input, whereas Dinosaur and OpenMS take in the ".mzXML" or
".mzML" files as input, which should also be centroided. It should be noted that when
using MaxQuant, we used all the features reported in "allPeptides.txt" for comparison.
Overall, MaxQuant has the full control over the MS data analysis, while Dinosaur and
OpenMS take the advantages of other tools to simplify their implementation.
Recently, DeepIso, a peptide detection tool based on convolutional neural network and
recurrent neural network, was released in 2019 [23]. The work has contributed to the use
of machine learning methods in the proteomics community. Since this software relies on
GPU computation and our work computes light-weighted ML models on CPU, we did not
compare with DeepIso.
2.3 MS/MS Search Engines
We previously mentioned the use of peptides identified from MS2 spectra to improve the
performance of peptide detection. In this research, two popular MS/MS search engines,
MS-GF+[12] and Comet[4], were used for peptide identification. MS-GF+ was used to
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build the training dataset and for performance evaluation. Comet was used for an addi-
tional test to verify whether the performance was impacted by the search engines used to
establish the benchmark data.
MS-GF+ is a database search tool for peptide identification by scoring MS/MS spectra.
The results are the identified peptides with their information such as m/z, RT , and charge
state. In addition to this scoring function, quality control factors such as FDR can be used
to select highly confident identified peptides. In the MS-GF+ scoring function, an E-value
is employed to evaluate individual PSMs, and the Q-value (labeled as PepQV alue in MS-
GF+ format) is used as a proxy for FDR [12]. MS-GF+ is available at https://github.
com/MSGFPlus/msgfplus/releases. Comet is another database search tool that is widely
used for peptide identification and allows for decoy search to control the FDR. The software
and a description of its usage can be retrieved from http://comet-ms.sourceforge.net.
Both software tools require the entire protein sequence information for the species of




Data Acquisition and Processing
In this chapter, we first describe the datasets used in the research, then provide the usage
and the parameter settings of the tools used in processing the datasets.
3.1 MS Data Acquisition
The most common species uploaded to ProteomeXchange are human, mouse, and yeast.
Initially, we chose the human datasets for training and testing the ML models; then, to
further test our models on the other species, we chose one mouse dataset and one yeast
dataset. We used the following four MS datasets as the benchmark datasets for testing
purposes:
• Mouse BV2: Trypsin digest of mouse BV-2 cell lysates [15] (ProteomeXchange:
PXD012238; measured with a Q Exactive instrument).
• Yeast S288c: Trypsin digest of yeast S288c cell lysates [11]. (ProteomeXchange:
PXD006631; measured with a Q Exactive instrument).
• Human HeLa-1: Trypsin digest of human HeLa cell lysates. (ProteomeXchange:
PXD022287; measured with an Orbitrap Fusion instrument).
• Human HeLa-2: A replicate experiment of Human HeLa-1 under the same exper-
imental conditions (instrument; temperature). (ProteomeXchange: PXD022287;
measured with an Orbitrap Fusion instrument).
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Another MS dataset was used as the training dataset to train the machine learning models
in MSTracer:
• Human HeLa Training Data: Trypsin digest of human HeLa cell lysates (ProteomeX-
change: PXD022287; measured with an Orbitrap Fusion instrument).
Human HeLa-1, Human HeLa-2, and Human HeLa Training Data are the datasets we have
uploaded to ProteomeXchange.
For the MS/MS protein search programs to perform a database search from the MS2
spectra, the protein sequence files of three species, UP000000589 (Mouse), UP000002311
(Yeast), and UP000005640 (Human) were downloaded from UniProt.
3.2 Data Processing
The pipeline for processing the ".raw" file using software tools is illustrated in Figure
3.1. MSConvert, a general format conversion tool developed by ProteoWizard, is used
to convert the ".raw" files to the ".mzML" or ".mzXML" format. Both MS spectra and
MS/MS spectra are centroided during the conversion. The following command line is used:
msconvert filename.raw --zlib --filter "peakPicking true [1,2]"
The input file format of MSTracer, Dinosaur, and OpenMS is ".mzML" or ".mzXML" files;
whereas the input of MaxQuant and MS-GF+ is ".raw" files.
The parameters for the MS-GF+ search are as follows: enzyme is set as trypsin; car-
bamidomethylating on Cysteine is used as fixed post translational modification; precursor
mass tolerance is set to 5 ppm; and isotope error range is set to [0, 1]. The following
command line is used for conversion:
[1] java -Xmx2000M -jar MSGFPlus.jar -s filename.mzML -t 5ppm
-ti 0,1 -tda 1 -d proteome.fasta
[2] java -Xmx2000M -cp MSGFPlus.jar edu.ucsd.msjava.ui.MzIDToTsv
-I filename.mzid -o filename.tsv
From the MS-GF+ output, the m/z, RT , and charge states of the identified PSMs with
PepQV alue ≤ 0.01 ( FDR≤ 0.01) are used as a benchmark to compare the performances
of different feature detection software tools.
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In the Comet search, parameters are modified in the file "comet.param". Precursor
mass tolerance is 10ppm; decoy search is set to turn on; isotope error range is set as [0, 1];
and other parameters remain as default. The command line is:
./comet.exe filename.mzML
In the Comet output, the PSMs at FDR ≤ 0.01 are retained. The FDR is calculated by
















In this chapter, we first introduce the overall pipeline of the algorithm design. Then, we
explicitly explain two scoring functions utilized as the variables in the Support Vector
Regression (SVR) model and the Neural Networks (NN) model. Finally, we describe in
details of the application and purpose of SVR and NN models in our algorithm.
4.1 Peptide Feature Detection
We discussed the general method for detecting peptide features in Section 2.1. Our pro-
gram, MSTracer, implements the second and the third step of the general method (trails
detection, isotope clustering), along with the application of ML models, SVR and NN.
Since our input data has already been centroided by MSConvert, we omit the first step
(data centroiding). In this section, we will describe the implementation of trails detection
and isotope clustering in MSTracer; in the next section, we will describe the building and
usage of the ML models.
The first step of MSTracer is to detect the trails (show in Figure 4.1 (A)). This is
realized by locating local maxima from the MS data. A trail consists of the signal peaks of
the same isotopic precursor ion that appear persistently at the same m/z (allowing for a
mass error tolerance) for a period of time. The signal intensity over time on a trail can be
represented as the function h(t). By locating the most intensive peak signal on each trail,
a precursor ion (either a monoisotope or an isotope) can be distinguished with confidence.
Then, we define the local maximum: A trail with intensity function h(t) is said to reach
the local maximum at retention time t if there is a time window [t1, t2] such that



















(A) Local Maxima Detection
(B) Isotope Clustering
(D) Quality Score Assignmnent
(C) Conicting Cluster Elimination
Figure 4.1: Workflow of MSTracer: (A) detection of local maxima on trails; (B) grouping
trails into isotope groups by m/z difference; (C) eliminating conflicting isotope groups by
the SVR score; and (D) the assignment of the final NN-based quality score.
(2) h(t) > h(t′) for t1 < t′ < t2, and




However, trails from different precursors with the similar m/z and RT may overlap (see
Figure 1.2 (C)). We strive to distinguish overlapping trails using the ML method described
in the third step.
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The second step is to cluster the trails (represented by local maxima) into isotope
groups (shown in 4.1 (B)). We define an isotope group as a group of isotopes formed by
clustering all the isotopes (represented by local maxima) for a monoisotope. A sequence of
local maxima forms an isotope group if they have similar RT and the m/z of every pair of
adjacent local maxima differ by m(proton)
k
for an integer k. Here, k is the charge state of the
candidate, and m(proton) is the atomic mass of a proton. We start searching for isotope
groups from k = 1, 2, ..., khi, where khi is the largest charge state appearing in the MS/MS
scans. For efficiency, we allow the user to set an upper bound for khi. It should be noted
that the local maxima can only be clustered once for the same charge state; however, they
can be repetitively clustered for a different charge state. Therefore, each local maximum
may belong to multiple isotope groups with different charge states and/or monoisotopic
mass. A set of isotope groups that share the same local maximum are called a conflicting
set of isotope groups.
The third step is to eliminate conflicting isotope groups (shown in Figure 4.1 (C)).
Isotope groups are candidates for peptide features. However, different isotope groups may
conflict with each other. We have to determine the isotope group that the trail is most
likely to belong to and remove the group in which the trail is falsely clustered. For example,
the local maxima in each isotope group with charge 2k contain a subset of local maxima
that form a charge-k isotope group. Allowing both charge states to exist will substantially
increase the false positives. Therefore, a scoring function is used to remove the inferior
isotope groups within a set of conflicting ones. After this filtration, the remaining isotope
groups become the peptide features. The scoring function used in this step is trained with
a support vector regression (SVR) model, described in Section 4.3.
The SVR scores are optimized to compare overlapping isotope groups. However, this
may not be optimal for comparing peptide features that do not overlap. Therefore, in the
fourth step, another scoring function is used to assess the quality of each peptide feature
(shown in Figure 4.1 (D)). The scoring function is trained with a neural network (NN)
model and is described in Section 4.4.
Finally, features with very close m/z and RT values and the same k are clustered to
remove redundancies. In each clustering operation, only the feature with the highest NN
quality score is maintained. The remaining peptide features and their quality scores are
output as the final results.
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4.2 Scoring Function
Two scoring functions, coelution coefficient and isotope shape coefficient are described in
this section. These scoring functions take an essential part in the SVR and NN models, as













Figure 4.2: Demonstration of calculating coelution coefficient. The blue curves represent
the intensity of the trails. The cosine similarity values of the adjacent trails (e.g., trail1
and trail2, trail2 and trail3) with respect to intensity should be calculated. Then, calculate
the average of the sum of the cosine similarity values.
The coelution coefficient measures how similar the intensities of the trails in one isotope
group change over RT . Different isotopes of the same peptide should coelute; therefore,
their trails should correlate well. The coelution coefficient of trails is measured as follows:
Given two trails h(t) and g(t), their coelution coefficient in time interval [ta, tb] is defined


















Here, hi is the intensity function of the i-th isotopic trail in the isotope group.
Figure 4.2 shows an example of a coelution coefficient calculation. The time interval is
composed of four sub-intervals with ta = t1, tb = t5. We first calculate coelution(trail1, trail2)
and coelution(trail2, trail3) (Equation 4.1) respectively. Here trail(t) is the intensity of
the trail at time t. Then we calculate the coefficient using 1
2
(coelution(trail1, trail2) +
coelution(trail2, trail3)) (Equation 4.2).
4.2.2 Isotope Shape Coefficient
The isotope shape coefficient represents the similarity of the theoretical isotope distribution
and the isotope distribution from real data. If we take the sum of the intensities of a
single isotope trail over a given RT for all the isotopes in a group, the intensity sums will
form the isotope shape, or the isotopic distribution. The more the isotopic distribution
resembles the theoretical isotope distribution, the higher the score assigned to the peptide
feature. The theoretical isotopic distribution at a given mass value is calculated by using
the average composition of elements in peptides. Similar to the coelution coefficient, the
isotope shape coefficient is defined as the cosine similarity between its isotopic distribution,
d, and its corresponding theoretical isotopic distribution, e. Given the time interval [t1, t2],


















Here, ei is the theoretical intensity sum of the i-th isotopic trail.
The theoretical isotopic distribution at a given mass value is calculated using the average
composition of C, H, O, N, and S elements in peptides without using the peptide sequence
information.
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4.3 Support Vector Machine-Based Conflicting Isotope
Groups Removal
As described in Step 3, we trained an SVR model to eliminate conflicting isotope groups
since a local maximum can be clustered into multiple isotope groups of different charge
states. We trained an SVR model to predict which isotope group most likely contains
the local maxima. Each isotope group has one SVR score; if one local maximum appears
in multiple isotope groups, only the isotope group with higher SVR score keeps the local
maximum. The other isotope groups are discarded if they no longer contain more than one
local maximum. Each remaining isotope group is a peptide feature.
The training dataset for the SVR model was obtained from Human HeLa Training Data
(described in Section 3.1) according to the following procedure: First, the isotope groups
obtained in Step 3 of the algorithm were compared to the PSMs identified by MS-GF+.
Specifically, among a set of isotope groups that share a trail (represented by local maxima),
the group that matches an identified PSM with respect to m/z, RT , and charge state is
labeled 1. The unmatched ones are labeled 0. We obtained 58996 negative samples and
2587 positive samples. To balance the training data, we selected all the positive samples
and randomly selected 2587 negative samples. The Python module sklearn v0.22.2.post1
was used to implement the model. The trained SVR model can then be used in a new
dataset to calculate a score between 0 and 1 for each isotope group. This score is used to
select the top-scoring isotope group from each conflicting set of isotope groups.
The SVR model was trained to predict the label by considering the following variables:
* the charge state.
* the number of local maxima.
* the coelution coefficient.
* the isotope shape coefficient.
We also considered other variables, such as the charge state and the intensity sum of the
trails. Several models were trained with different combinations of these variables. Finally,
the above variables were determined to build the final model based on its performance
among all models. The variables used in each model and the test results are described in
Section 5.1.1.
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4.4 Neural Network-Based Quality Score
As described in Step 4, an NN model was trained to assign a quality score to each detected
feature. The network was trained using the Human HeLa Training Data. The positive
samples are the features that match the identified PSMs and are labeled 1; the negative
samples are those that do not match and are labeled 0. To implement the NN model, we
used Tensorflow (v1.14.0). We considered the following variables to build the NN model:
* the number of local maxima.
* the coelution coefficient.
* the isotope shape coefficient.
* the ratio between the trail intensity and the total peak intensity in the surrounding
area. Suppose the trails can be fit into a rectangle area [t1, t2] × [m1,m2]. Here
[t1, t2] is the RT interval and [m1,m2] is the m/z interval. The surrounding area
refers to the rectangle [t1, t2]× [m1 − 1.5,m2 + 1.5].
Following the same procedure as that for the SVR model, for the NN model, we tested
different combinations of variables, including the charge state and the intensity sum of the
trails. We also adjusted the NN construction in the model with respect to the number of
layers, the number of nodes in each layer, and the number of epochs to achieve the best
performance. The final model has three hidden layers, each of which has 100 nodes, and
the layers are fully connected. The model was trained with 100 epochs. The results for
each tested model are presented in Section 5.1.1.
The value predicted by the NN model is a probability indicating the likelihood of the
feature corresponding to a peptide identifiable by MS/MS. This probability p is converted








In this chapter, we evaluate the performance of MSTracer as well as MaxQuant, Dinosaur,
and OpenMS by conducting the sensitivity test, the quality score analysis, and the re-
producibility test. We also illustrate the combine use of multiple software tools and the
runtime. Finally, we discuss the results from the performance evaluation.
5.1 Performance Evaluation
In this section, we first describes the selection of the best-performed variables used in the
SVR and NN models, and the sensitivity of MSTracer compared to the other software
tools. Next, we analyze the distribution of the quality score on the testing datasets and
introduce a cut-off score for high- and low-quality peptide features. Then, we illustrate
the combine use of multiple software tools and its advantage in improving the quality of
peptide features, where Venn diagrams are presented to summarize the results. Lastly,
we demonstrate a reproducibility test on replicate datasets and report the runtime of all
software tools on the datasets.
Four test datasets, Mouse BV2, Yeast S288c, Human HeLa-1, and Human HeLa-2, were
used for assessing the performance. For each MS file, peptide features were detected from
the MS scans using four software tools: MaxQuant, Dinosaur, OpenMS, and MSTracer.
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5.1.1 Sensitivity
The sensitivity test measures how well an algorithm detects the features of the peptides
identifiable by a database search. For a given peptide feature detection result, the sensitiv-
ity is defined as the percentage of PSMs that match one of the detected peptide features.
The detected peptide features are compared to the PSMs identified from the MS/MS spec-
tra by MS-GF+ and Comet, respectively. The precursor of a PSM and a detected feature
are matched if the conditions below are satisfied:
* Their m/z match is within a ±10 ppm error.
* Their RT match is within a ±0.5 min error.
* Their charge states match.
To optimize the SVR and NN models, we constructed the model with several combinations
of variables and tested the sensitivity. The model with the best performance was selected
as the final model. The variables we considered are listed as below:
(1) The charge state
(2) The number of local maxima
(3) The coelution coefficient
(4) The isotope shape coefficient
(5) The scaled intensity sum of the trails, calculated as the real intensity sum divided
by window size and the 100th largest intensity sum in the clusters.
(6) the ratio between the trail intensity and the total peak intensity in the surround-
ing area. Suppose the trails can be fit into a rectangular area [t1, t2]× [m1,m2].
Here [t1, t2] is the RT interval and [m1,m2] is the m/z interval. The surrounding
area refers to the rectangle [t1, t2]× [m1 − 1.5,m2 + 1.5].
An extra tree classifier was applied to decide the combinations of the variables. The
classifier fits randomized decision trees and estimates feature importance. The importance
of each variable is represented by weights, as shown in Table 5.1.
We selected the groups of variables according to the weights of the variables. Initially,
we included all variables; next, we eliminated the least significant variables in the decision
trees one at a time. The variable combinations for the SVR model were:
a. (1) (2) (3) (4) (5) (6).
b. (1) (2) (3) (4) (6).
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c. (1) (2) (3) (4).
d. (1) (2) (4).
e. (2) (3) (4) (6).
f . (2) (3) (4).
Table 5.2 shows that SVR models b, c, and d significantly outperformed a, e, and f
across the four datasets. Their sensitivity was higher even though they produced fewer
results. We choose model c as the final model.
(1) (2) (3) (4) (5) (6)
Weight 0.504 0.141 0.088 0.140 0.061 0.066
Table 5.1: Weights of variables.
Sensitivity a b c d e f
Mouse BV2 61.29% 89.88% 91.01% 91.09% 88.36% 88.52%
(1233309) (1223827) (1226329) (1214624) (1082062) (108077)
Yeast S288c 71.93% 98.26% 98.27% 98.05% 94.69% 94.91%
(110049) (109278) (109238) (109227) (105957) (105939)
Human HeLa-1 76.55% 96.63% 97.19% 97.31% 95.76% 95.81%
(481783) (474695) (474105) (472708) (430391) (429677)
Human HeLa-2 76.26% 96.73% 97.19% 97.26% 95.74% 95.81%
(463809) (457607) (457297) (455728) (413544) (412949)
Table 5.2: The sensitivity of model a-f for the four datasets. Numbers in the brackets are
the number of peptide features after eliminating conflicting isotope clusters.
Next, we built the NN models based on the same variables. We eliminated variable (5)
since it showed a notable negative effect on the model. The variable combinations were:
a. (1) (2) (3) (4) (6).
b. (1) (2) (3) (4).
c. (1) (2) (4).
d. (2) (3) (4) (6).
e. (2) (3) (4).
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We ranked the peptide features in descending order by the quality score that the NN model
assigned and then tested the sensitivity of the top N peptide features. The results, shown




































































































































































































Figure 5.1: Sensitivity test on NN model a, b, c, d, and e for the four datasets. The
x-axis is the top N peptide features reported by the model. The y-axis (sensitivity) is the
percentage of the benchmark peptides that are included in the reported features.
Finally, SVR model c and NN model d were selected for our algorithm. Figure 5.2
shows the sensitivity of MSTracer and other software tools with respect to the number of
reported features with PSMs identified by MS-GF+. When a similar number of features
are reported, MSTracer is able to identify more benchmark features (features matching the
identified PSMs) than any other tool. The PSMs in Figure 5.3 were identified using Comet,














































































































































































































































































































Figure 5.2: The sensitivity of MSTracer, MaxQuant, Dinosaur and OpenMS on the four
datasets, where ground truth PSMs are matched with MS-GF+. The x-axis is the number
of features reported by each software. The y-axis (the sensitivity) is the percentage of the
benchmark peptides that are included in the reported features. By adjusting the score
threshold, MSTracer can report different number of features. Therefore, its sensitivity is a
























































































































































































































































































































Figure 5.3: The sensitivity of MSTracer, MaxQuant, Dinosaur and OpenMS on the four
datasets, where ground truth PSMs are matched with Comet at FDR ≤ 0.01
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different feature detection programs are not greatly impacted by the search engines used
to establish the benchmark data.
5.1.2 Quality Score Analysis
We designed the quality score to build a ranking system; we then identified a breaking point
which separate "good" and "bad" peptide features. Figure 5.4 shows the quality score
distribution of the features detected by MSTracer for the four test datasets, Mouse BV2,
Yeast S288c, Human HeLa-1, and Human HeLa-2. The scores for PSMs are also plotted.
The figures show that the quality score distribution is approximately an aggregation of two
Gaussian distributions. Moreover, most of the features that match an identified PSM have
a quality score above −1. This indicates that the score −1 can be used to separate high-
and low-quality features and that it can be used as an empirical cut-off score to filter the
detected features.
5.1.3 Intersection of the Results of MSTracer and Other Software
Prior to our research, peptide features are not assigned with scores by a ranking system. To
generate high-quality peptide features, multiple software tools by taking their intersection.
We wanted to investigate the use of MSTracer combined with other tools to see 1) how
well the quality separating system in MSTracer works with the other software tools and
2) how combining software might affect the results. Figure 5.5 presents Venn diagrams
showing the features detected by the three best-performing tools: MSTracer, Dinosaur,
and MaxQuant. To obtain high-quality peptide features, a score threshold of −1 (found
in Section 5.1.2) is used to filter the results from MSTracer.
In the Venn diagrams, the intersections of the results from the three tools are illustrated.
The parentheses indicated on the diagrams include a number and a percentage. The
number is how many features from that intersection match the PSMs, and the percentage
is simply the number divided by the number of all features from that intersection.
The diagrams indicate that the number of the features matched with PSMs identified
by all three tools is higher than those who are only detected by two tools or less. For
example, in the Mouse BV2 dataset, 26.00%(17, 348/66, 717) of features detected by all
three tools were benchmark features. In contrast, only 5.55%, 0.09%, and 0.88% of the fea-
tures detected by only MSTracer, Dinosaur, and MaxQuant, respectively, were benchmark
features.
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(A) Mouse BV2 (B) Yeast S288c
(C) Human HeLa-1 (D) Human HeLa-2
Figure 5.4: The quality score distribution of the features detected by MSTracer and of
those that also matched an identified PSM for the four datasets. The dashed vertical lines
illustrate a quality score, -1.
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Figure 5.5: Venn diagrams showing the features detected by MSTracer, MaxQuant, and
Dinosaur for the four datasets. The numbers in parentheses are the numbers of benchmark
features and their corresponding percentages in the features reported.
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Human HeLa-1 Human HeLa-2
84.045 84.258 84.461 84.867 85.07284.05983.933 84.105 84.278 84.447 84.62583.761
Figure 5.6: Heatmap view of Human HeLa-1 and Human HeLa-2. The bottom images
show the patterns of identical peptide features from the two datasets.
We also found that combining MSTracer with other software tended to increase the per-
centage of benchmark peptides. For example, the datasets Yeast S228c, Dinosaur+MSTracer
(15.23%) and MaxQuant+MSTracer (19.99%) reported a higher percentage of benchmark
peptides than MaxQuant+Dinosaur (9.50%). The Venn Diagram for Human HeLa-1 and
Human HeLa-2 show similar results.
5.1.4 Reproducibility
The reproducibility test evaluates whether the program is able to reproduce the same
result on the datasets from replicate experiments. Human HeLa-1 and Human HeLa-2 are





















Figure 5.7: Venn diagrams and a plot demonstrating the reproducibility test results on
Human HeLa-1 (blue in Venn diagram) and Human HeLa-2 (orange in Venn diagram)
for MaxQuant, Dinosaur, OpenMS, and MSTracer. The percentage in the parentheses
represents proportion of intersecting peptide features for Human HeLa-1 and Human HeLa-
2, respectively. In the results of MSTracer, the Venn diagram illustrates the result of all
reported peptide features; the plot illustrates the results of the reported peptide features.
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MS scans should show similar patterns if the MS experiment is fully reproducible (shown
in Figure 5.6) and the detected features from the two datasets are expected to have a large
intersection. However, we know that LC-MS/MS is not fully reproducible. Therefore, the
irreproducibility comes from both the software and the nature of the data. The images at
the bottom of Figure 5.6 show that identical peptide features in the two datasets have the
same m/z value, whereas the RT values may differ. Therefore, we allow higher tolerance
in the RT matching condition than in the PSM matching condition. We consider that two
features to match if
* their m/z values match within a ±10 ppm error,
* their RT values match within a ±1 min error, and
* their charge states match.
The reproducibility test result is shown in Figure 5.7. In the figure, the percentage in-
dicates the proportion of intersecting features for the two datasets. For example, for
Human HeLa-1, the proportion intersecting with Human HeLa-2 detected by MaxQuant is
104237/(104237 + 45572) = 69.6%. The reproducibility of MSTracer for features with low
and high thresholds ranges from around 61% to 68%. OpenMS produces almost identical
outputs on the two replicate datasets; however, the number of output is remarkably lower
than that of the other software. Dinosaur reproduces the results better than MaxQuant
and MSTracer. Above all, the reproducibility of MSTracer, MaxQuant, and Dinosaur is
no higher than 75%.
5.1.5 Runtime
Table 5.3 shows the runtime of each software tool on the benchmark datasets. It should
be noted that the runtime for MaxQuant includes both MS peptide detection and MS/MS
peptide identification, since the program sequentially conducts MS/MS identification after
MS peptide detection without pause. The runtime of the other programs is for the MS
peptide detection only.
5.2 Discussion
In a bottom-up DDA mass spectrometry experiment, the instrument does not have suffi-
cient duty cycles to produce MS/MS scans of each peptide in the sample. However, these
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Mouse BV2 Yeast S288c Human HeLa-1 Human HeLa-2
MSTracer (MS1) 33 12 11 11
MaxQuant (MS1+MS2) 22 3 145 145
Dinosaur (MS1) 6 3 2 2
OpenMS (MS1) 65 50 18 18
Table 5.3: Runtime (min) of MSTracer, MaxQuant, Dinosaur, and OpenMS on the four
datasets on a Linux machine (Intel Core i7-6770HQ CPU with 16 GB of memory). MS1
represents MS peptide detection from MS1 spectra, and MS2 represents MS/MS peptide
identification from MS2 spectra.
peptides still produce traces in the MS scans. These traces are called peptide features and
can provide important information about the corresponding peptides, such as m/z, charge
state, RT , and relative quantity. Accurate detection of these features is the first step in
utilizing such information. This paper presents a new software application, MSTracer, for
peptide feature detection.
The built-in ML models are essential implementations in MSTracer. When building the
models, we extracted several pieces of information from the intensity of peptide features:
Based on the change of the intensity of trails over RT , we obtained the coelution coefficient.
Based on the sum intensity of each isotope in a cluster, we obtained the isotope shape
coefficient. We also obtained the total intensity of isotope clusters and the relative intensity
of each isotope cluster in the surrounding area. We tested various combinations of these
variables in the SVR and NN training and finalized a best-performing model.
A unique feature of MSTracer is that, unlike other software tools, it assigns a quality
score to each detected peptide feature. The quality score can be used to rank the results
and offers users the flexibility to consider trade-offs between result accuracy and sensitivity
(Figure 5.5). This feature also facilitated a fair comparison between MSTracer and other
software tools, as it allowed us to truncate the results from MSTracer to give the same
number of peptide features as another tool, thereby limiting the comparison strictly to
sensitivity (i.e., the percentage of identifiable PSMs detected by each tool). MSTracer
outperformed every other software tool in these comparisons (Figure 5.2).
It is noteworthy that a true peptide feature may not necessarily be identified by the
MS/MS scans. In fact, the peptide may not even be acquired by the mass spectrometer
to produce an MS/MS scan. On one hand, this makes the feature detection from MS
scans particularly useful. On the other hand, it makes it difficult to determine whether a
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prediction is a false positive and making it hard to compare different prediction algorithms
based on precision or ROC curves.
As Figure 5.4 shows, the quality score can be used to effectively separate high- and low-
quality peptide features. Moreover, the score distributions on the four separate datasets are
very similar, indicating highly robust scores. We determined an empirical score threshold
of -1 to filter the results of MSTracer.
The potential of combinations of multiple software tools is examined in Figure 5.5, which
shows that peptide features detected by two or more software tools have a higher chance
of matching the identifiable PSMs than those detected by only one tool. This confirms the
common assumption that results from multiple tools are more reliable than those from a
single tool. It can also be seen that MSTracer contributed more to the overlapping peptide
features than each of the other tools. Moreover, among the peptide features detected by
only one tool, those detected by MSTracer have a higher chance of matching the PSMs
identified by MS/MS. All these findings suggest that MSTracer can identify not only more
but also higher quality peptide features than the other tools.
If we only regard peptide features detected by at least two of the three software tools
as correct, then the combination of the three tools was able to detect 178,927, 139,627,
133,394, and 132,374 peptide features from the MS1 spectra in the mouse, yeast, HeLa-1,
and HeLa-2 datasets, respectively. Among these detected peptide features, only 29,275
(16%), 36,693 (26%), 50,111 (38%), and 49,357 (37%), respectively, were identified by the
MS/MS spectra. This lower identification rate achieved by MS/MS is the result of two
factors: not every peptide feature is acquired for MS/MS and not every MS/MS spectra
is identifiable by a database search. This suggests that MS scans are a rich source of
information that can be utilized by future proteomics software tools. Furthermore, there
is much room to improve the number of identified peptides with new and more intelligent
MS/MS acquisitions.
A novel reproducibility test was examined and is shown in Figure 5.7. Reproducibility
can be affected by both datasets and the peptide detection software. Specifically, noises
caused by slight changes in experimental conditions and the accuracy of the instrument
can largely affect the results. Given that none of the software except for OpenMS has fairly
high reproducibility, further study is warranted to investigate the source of irreproducibility
and to either reduce or exploit it.
The runtime of MSTracer and the other software tools is shown in Table 5.3. Con-
sidering producing an MS dataset takes hours to generate on the mass spectrometer, all
software tools have acceptable runtime. Within this time range, the detection sensitivity
and accuracy become more important to compare.
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Chapter 6
Conclusions and Future Work
In this thesis, we introduced a software tool, MSTracer, for peptide feature detection from
the MS1 spectra of LC-MS/MS map.
In the beginning, we described the importance of the efficient use of MS1 spectra data
and the challenges of the accurate detection of peptide features from MS1 spectra. Next, we
reviewed current software tools and their methods. Then, we proposed a novel algorithm
that combines SVR and NN models.
The algorithm was established on the basic pipeline of peptide feature detection, where
it implements the steps of trail construction and isotope clustering. During the process, all
possible isotope groups were detected for being further analyzed by SVR and NN models.
SVR selects the peptide features with high confidence from conflicting isotope groups, and
NN assigns a quality score to each reported peptide feature. Variables used in the SVR
and NN models were carefully selected to optimize the models.
During the performance evaluation, the sensitivity of MSTracer outperformed the exist-
ing software tools, MaxQuant, Dinosaur, and OpenMS for the test datasets from different
species - human, mouse, and yeast. Furthermore, the results from using the PSMs from
two MS/MS search tools revealed that the sensitivity test result of MSTracer is not affected
by which search engine is used for the test. In addition, MSTracer assigns quality scores
to the reported peptide features. From a histogram of the quality score distribution, we
concluded that the value −1 can be used to separate high- and low-quality peptide features.
We then applied this finding to MSTracer to evaluate the combine use of multiple software
tools, where we took the features of quality score > −1. The evaluation showed that the
joint use of multiple software increases the probability of the peptide features matching
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PSMs. Lastly, we proposed a new concept, reproducibility, which measures how identical
the peptide features that the algorithm detects for identical experimental samples.
For the future work, we propose the following avenues:
• One avenue for future research is to improve the performance of the ML models. In
our current work, the ML models have been trained with a small human cell dataset
only. The training dataset could be expanded to train the models for specific species
and specific widely used instruments (e.g., Q Exactive, Orbitrap Fusion, LTQ). We
anticipate that providing users with options regarding species and instruments will
further improve the sensitivity and accuracy of MSTracer.
• Another avenue is to add functionalities to MSTracer, including monoisotope picking,
that are comparable with MS/MS search tools. In addition, as demonstrated in the
reproducibility test, the robustness of our program can be further improved.
• Last but not least, we plan to incorporate MSTracer into a full protein MS dataset
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